Development of a rapid, quantitative method for LDL subfractionation with use of the quantimetrix lipoprint LDL system

D. M. Hoefner, S. D. Hodel, J. F. O'Brien, E. L. Branum, D. Sun, Irene Meissner, J. P. McConnell

Research output: Contribution to journalArticle

188 Citations (Scopus)

Abstract

Background: Recent evidence suggests that the presence of small, dense LDL is independently associated with increased risk of developing coronary artery disease. Current methods to subfractionate LDL are timeconsuming and/or technically demanding. Therefore, we have sought the development of a less complex LDL subfractionation procedure. Methods: LDL subfractions were separated using the Quantimetrix LipoprintTM LDL System. High-resolution 3% polyacrylamide gel tubes were scanned densitometrically (610 rim) with a Helena EDC system. A computerized method to identify and quantitatively score the resolved LDL subfractions was developed. Results from the Quantimetrix method were compared using 51 plasma samples with values obtained by nondenaturing gradient gel electrophoresis (NDGGE) and nuclear magnetic resonance (NMR) spectroscopy. Results: LDL subfractionation scores correlated significantly (P < 0.05) with triglyceride, HDL-cholesterol, apolipoprotein B100, and LDL-cholesterol/apolipoprotein B100 (r = 0.591, -0.392, 0.454, and -0.411, respectively). For 51 samples, the Quantimetrix method classified 21 with small, 14 with intermediate, and 16 with large LDL. Of the 21 samples classified as small by Quantimetrix, 20 (95%) were classified as small (n = 18) or intermediate (n = 2) by NDGGE. All of the 16 specimens classifled as large by Quantimetrix were either large (n = 14) or intermediate (n = 2) by NDGGE. LDL score was inversely correlated (r = -0.674; P <0.0001) with LDL particle size determined by NMR spectroscopy. Conclusions:A quantitative method for the assessment of LDL particle size phenotype was developed using the Quantimetrix Lipoprint LDL System. The method can be performed in less than 3 h in batch mode and is suitable for routine use in clinical laboratories.

Original languageEnglish (US)
Pages (from-to)266-274
Number of pages9
JournalClinical Chemistry
Volume47
Issue number2
StatePublished - Feb 20 2001

Fingerprint

Electrophoresis
Apolipoproteins
Gels
Particle Size
Nuclear magnetic resonance spectroscopy
oxidized low density lipoprotein
Magnetic Resonance Spectroscopy
Particle size
Clinical laboratories
LDL Cholesterol
HDL Cholesterol
Coronary Artery Disease
Triglycerides
Phenotype
Plasmas

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Hoefner, D. M., Hodel, S. D., O'Brien, J. F., Branum, E. L., Sun, D., Meissner, I., & McConnell, J. P. (2001). Development of a rapid, quantitative method for LDL subfractionation with use of the quantimetrix lipoprint LDL system. Clinical Chemistry, 47(2), 266-274.

Development of a rapid, quantitative method for LDL subfractionation with use of the quantimetrix lipoprint LDL system. / Hoefner, D. M.; Hodel, S. D.; O'Brien, J. F.; Branum, E. L.; Sun, D.; Meissner, Irene; McConnell, J. P.

In: Clinical Chemistry, Vol. 47, No. 2, 20.02.2001, p. 266-274.

Research output: Contribution to journalArticle

Hoefner, DM, Hodel, SD, O'Brien, JF, Branum, EL, Sun, D, Meissner, I & McConnell, JP 2001, 'Development of a rapid, quantitative method for LDL subfractionation with use of the quantimetrix lipoprint LDL system', Clinical Chemistry, vol. 47, no. 2, pp. 266-274.
Hoefner, D. M. ; Hodel, S. D. ; O'Brien, J. F. ; Branum, E. L. ; Sun, D. ; Meissner, Irene ; McConnell, J. P. / Development of a rapid, quantitative method for LDL subfractionation with use of the quantimetrix lipoprint LDL system. In: Clinical Chemistry. 2001 ; Vol. 47, No. 2. pp. 266-274.
@article{c682130b1bc94d52981ef2e0d90eaf26,
title = "Development of a rapid, quantitative method for LDL subfractionation with use of the quantimetrix lipoprint LDL system",
abstract = "Background: Recent evidence suggests that the presence of small, dense LDL is independently associated with increased risk of developing coronary artery disease. Current methods to subfractionate LDL are timeconsuming and/or technically demanding. Therefore, we have sought the development of a less complex LDL subfractionation procedure. Methods: LDL subfractions were separated using the Quantimetrix LipoprintTM LDL System. High-resolution 3{\%} polyacrylamide gel tubes were scanned densitometrically (610 rim) with a Helena EDC system. A computerized method to identify and quantitatively score the resolved LDL subfractions was developed. Results from the Quantimetrix method were compared using 51 plasma samples with values obtained by nondenaturing gradient gel electrophoresis (NDGGE) and nuclear magnetic resonance (NMR) spectroscopy. Results: LDL subfractionation scores correlated significantly (P < 0.05) with triglyceride, HDL-cholesterol, apolipoprotein B100, and LDL-cholesterol/apolipoprotein B100 (r = 0.591, -0.392, 0.454, and -0.411, respectively). For 51 samples, the Quantimetrix method classified 21 with small, 14 with intermediate, and 16 with large LDL. Of the 21 samples classified as small by Quantimetrix, 20 (95{\%}) were classified as small (n = 18) or intermediate (n = 2) by NDGGE. All of the 16 specimens classifled as large by Quantimetrix were either large (n = 14) or intermediate (n = 2) by NDGGE. LDL score was inversely correlated (r = -0.674; P <0.0001) with LDL particle size determined by NMR spectroscopy. Conclusions:A quantitative method for the assessment of LDL particle size phenotype was developed using the Quantimetrix Lipoprint LDL System. The method can be performed in less than 3 h in batch mode and is suitable for routine use in clinical laboratories.",
author = "Hoefner, {D. M.} and Hodel, {S. D.} and O'Brien, {J. F.} and Branum, {E. L.} and D. Sun and Irene Meissner and McConnell, {J. P.}",
year = "2001",
month = "2",
day = "20",
language = "English (US)",
volume = "47",
pages = "266--274",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "2",

}

TY - JOUR

T1 - Development of a rapid, quantitative method for LDL subfractionation with use of the quantimetrix lipoprint LDL system

AU - Hoefner, D. M.

AU - Hodel, S. D.

AU - O'Brien, J. F.

AU - Branum, E. L.

AU - Sun, D.

AU - Meissner, Irene

AU - McConnell, J. P.

PY - 2001/2/20

Y1 - 2001/2/20

N2 - Background: Recent evidence suggests that the presence of small, dense LDL is independently associated with increased risk of developing coronary artery disease. Current methods to subfractionate LDL are timeconsuming and/or technically demanding. Therefore, we have sought the development of a less complex LDL subfractionation procedure. Methods: LDL subfractions were separated using the Quantimetrix LipoprintTM LDL System. High-resolution 3% polyacrylamide gel tubes were scanned densitometrically (610 rim) with a Helena EDC system. A computerized method to identify and quantitatively score the resolved LDL subfractions was developed. Results from the Quantimetrix method were compared using 51 plasma samples with values obtained by nondenaturing gradient gel electrophoresis (NDGGE) and nuclear magnetic resonance (NMR) spectroscopy. Results: LDL subfractionation scores correlated significantly (P < 0.05) with triglyceride, HDL-cholesterol, apolipoprotein B100, and LDL-cholesterol/apolipoprotein B100 (r = 0.591, -0.392, 0.454, and -0.411, respectively). For 51 samples, the Quantimetrix method classified 21 with small, 14 with intermediate, and 16 with large LDL. Of the 21 samples classified as small by Quantimetrix, 20 (95%) were classified as small (n = 18) or intermediate (n = 2) by NDGGE. All of the 16 specimens classifled as large by Quantimetrix were either large (n = 14) or intermediate (n = 2) by NDGGE. LDL score was inversely correlated (r = -0.674; P <0.0001) with LDL particle size determined by NMR spectroscopy. Conclusions:A quantitative method for the assessment of LDL particle size phenotype was developed using the Quantimetrix Lipoprint LDL System. The method can be performed in less than 3 h in batch mode and is suitable for routine use in clinical laboratories.

AB - Background: Recent evidence suggests that the presence of small, dense LDL is independently associated with increased risk of developing coronary artery disease. Current methods to subfractionate LDL are timeconsuming and/or technically demanding. Therefore, we have sought the development of a less complex LDL subfractionation procedure. Methods: LDL subfractions were separated using the Quantimetrix LipoprintTM LDL System. High-resolution 3% polyacrylamide gel tubes were scanned densitometrically (610 rim) with a Helena EDC system. A computerized method to identify and quantitatively score the resolved LDL subfractions was developed. Results from the Quantimetrix method were compared using 51 plasma samples with values obtained by nondenaturing gradient gel electrophoresis (NDGGE) and nuclear magnetic resonance (NMR) spectroscopy. Results: LDL subfractionation scores correlated significantly (P < 0.05) with triglyceride, HDL-cholesterol, apolipoprotein B100, and LDL-cholesterol/apolipoprotein B100 (r = 0.591, -0.392, 0.454, and -0.411, respectively). For 51 samples, the Quantimetrix method classified 21 with small, 14 with intermediate, and 16 with large LDL. Of the 21 samples classified as small by Quantimetrix, 20 (95%) were classified as small (n = 18) or intermediate (n = 2) by NDGGE. All of the 16 specimens classifled as large by Quantimetrix were either large (n = 14) or intermediate (n = 2) by NDGGE. LDL score was inversely correlated (r = -0.674; P <0.0001) with LDL particle size determined by NMR spectroscopy. Conclusions:A quantitative method for the assessment of LDL particle size phenotype was developed using the Quantimetrix Lipoprint LDL System. The method can be performed in less than 3 h in batch mode and is suitable for routine use in clinical laboratories.

UR - http://www.scopus.com/inward/record.url?scp=0035134537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035134537&partnerID=8YFLogxK

M3 - Article

VL - 47

SP - 266

EP - 274

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 2

ER -